Idexx Laboratories Inc (IDXX)

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
$3.84 (-0.85%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0

About

Business overview of Idexx Laboratories Inc (IDXX)
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.

Key Insights

Critical company metrics and information
  • Share Price

    $447.44
  • Market Cap

    $36.64 Billion
  • Total Outstanding Shares

    81.89 Million Shares
  • Total Employees

    11,000
  • Dividend

    No dividend
  • IPO Date

    June 21, 1991
  • SIC Description

    In Vitro & In Vivo Diagnostic Substances
  • Homepage

    https://www.idexx.com

Historical Stock Splits

If you bought 1 share of IDXX before November 27, 2007, you'd have 4 shares today.
Execution DateSplit Amount
June 16, 20152-for-1
November 27, 20072-for-1

Cash Flow Statement

October 1, 2023 to September 30, 2024
MetricValue
Net Cash Flow From Investing Activities$-197.65 Million
Net Cash Flow From Financing Activities$-747.13 Million
Net Cash Flow From Operating Activities, Continuing$916.83 Million
Net Cash Flow From Financing Activities, Continuing$-747.13 Million
Net Cash Flow$-23.06 Million
Exchange Gains/Losses$4.90 Million
Net Cash Flow From Operating Activities$916.83 Million
Net Cash Flow From Investing Activities, Continuing$-197.65 Million
Net Cash Flow, Continuing$-27.96 Million

Income Statement

October 1, 2023 to September 30, 2024
MetricValue
Gross Profit$2.33 Billion
Revenues$3.84 Billion
Net Income/Loss Available To Common Stockholders, Basic$866.24 Million
Income Tax Expense/Benefit$226.87 Million
Basic Earnings Per Share$10.46
Basic Average Shares$248.04 Million
Net Income/Loss Attributable To Parent$866.24 Million
Net Income/Loss Attributable To Noncontrolling Interest$0.00
Operating Income/Loss$1.11 Billion
Income/Loss From Continuing Operations After Tax$866.24 Million
Diluted Average Shares$250.39 Million
Net Income/Loss$866.24 Million
Research and Development$213.88 Million
Benefits Costs and Expenses$2.75 Billion
Other Operating Expenses$1.01 Billion
Cost Of Revenue$1.51 Billion
Diluted Earnings Per Share$10.36
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic$0.00
Provision For Loan, Lease, And Other Losses$5.17 Million
Income/Loss From Continuing Operations Before Tax$1.09 Billion
Operating Expenses$1.22 Billion
Costs And Expenses$2.75 Billion
Income Tax Expense/Benefit, Deferred$-62.43 Million
Preferred Stock Dividends And Other Adjustments$0.00

Balance Sheet

October 1, 2023 to September 30, 2024
MetricValue
Other Current Liabilities$739.64 Million
Noncurrent Liabilities$723.49 Million
Current Liabilities$1.01 Billion
Other Non-current Assets$1.09 Billion
Inventory$389.80 Million
Equity$1.62 Billion
Noncurrent Assets$1.92 Billion
Liabilities And Equity$3.35 Billion
Accounts Payable$110.60 Million
Fixed Assets$717.75 Million
Liabilities$1.73 Billion
Equity Attributable To Noncontrolling Interest$0.00
Wages$158.99 Million
Equity Attributable To Parent$1.62 Billion
Assets$3.35 Billion
Intangible Assets$106.89 Million
Prepaid Expenses$57.22 Million
Current Assets$1.43 Billion
Other Current Assets$986.72 Million

Historical Dividends

Announcement DatePayment DateRecord DateAmountFrequency
No historical dividends
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.